Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
844.27
-26.09 (-3.00%)
Official Closing Price
Updated: 7:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
November 29, 2024
Via
Benzinga
Behind the Scenes of Eli Lilly's Latest Options Trends
November 29, 2024
Via
Benzinga
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
November 29, 2024
Analysts are concerned about Viking's ability to compete in the lucrative obesity drug market, dominated by Eli Lilly and Novo Nordisk.
Via
Benzinga
Does Billionaire Israel Englander Know Something Wall Street Doesn't? The Billionaire Investor Just Sold 8.1 Million Shares of Walmart Stock.
November 29, 2024
Israel Englander's Millennium Management reduced its stake in Walmart by 69% last quarter.
Via
The Motley Fool
Stock Market Hits Highs Despite Trump Tariff Threats, Nvidia, Tech Turkeys: Weekly Review
November 29, 2024
The Nasdaq isn't at a high, but it isn't far off either.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
November 27, 2024
Via
The Motley Fool
(LLY) - Analyzing Eli Lilly's Short Interest
November 25, 2024
Via
Benzinga
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
November 28, 2024
Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines.
Via
MarketBeat
Topics
Government
Exposures
COVID-19
Political
Product Safety
Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?
November 28, 2024
Via
The Motley Fool
The Ultimate Pharmaceutical Stock to Buy With $1,000 Right Now
November 27, 2024
Via
The Motley Fool
Tradepulse Power Inflow Alert: Eli Lilly & Company Climbs Over 22 Points After Alert
November 26, 2024
Via
Benzinga
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
November 26, 2024
The U.S. stock market traded mixed on Tuesday morning, with major indices showing tight movements as investors awaited the release of the Federal Reserve's November meeting minutes.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Are Diet Drug Companies Over The Hump?
November 20, 2024
Eli Lilly made a reversal bottom low on Monday after a gap lower. Today’s price action was confirmation.
Via
Talk Markets
Topics
Stocks / Equities
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
The Biden Administration's proposal expands Medicare and Medicaid coverage for anti-obesity drugs, cutting costs for millions while addressing the obesity crisis.
Via
Benzinga
Eli Lilly Stock Is Rising Tuesday: What's Going On?
November 26, 2024
Eli Lilly And Co (NYSE:LLY) shares are trading higher Tuesday after the Biden-Harris Administration proposed a new rule to expand coverage of anti-obesity medications for Americans with Medicare and...
Via
Benzinga
Amgen Crashes 12% After Weight-Loss Drug Meets Eli Lilly's In A Key Test
November 26, 2024
Over the course of a year, Amgen's MariTide helped patients lose about 20% of their body weight.
Via
Investor's Business Daily
Thankful Investors - Last 5 Years
November 25, 2024
A look at the 25 best-performing stocks in the S&P 1500 on a total return basis over the last five years.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Exposures
US Equities
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
November 25, 2024
Via
The Motley Fool
Is It Time to Sell Eli Lilly and Pfizer Stocks?
November 20, 2024
Via
The Motley Fool
When It Is Too Late To Trade
November 23, 2024
Is it too late to get started with swing trading when considering the stock market rally, or should a new trader wait for a market crash or pullback?
Via
Talk Markets
Topics
Stocks / Equities
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?
November 23, 2024
Via
The Motley Fool
Here's How Much You Would Need to Invest in This Unstoppable Vanguard ETF Today to Grow Your Portfolio to $1 Million or More by Retirement
November 23, 2024
Via
The Motley Fool
Topics
ETFs
2 Incredible Growth Stocks to Buy With $1,000 Right Now
November 23, 2024
Via
The Motley Fool
Investing in Pharma Stocks? Check These 3 Things First
November 22, 2024
Via
The Motley Fool
Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
November 22, 2024
Robert F. Kennedy hasn't overtly commented on how he would handle GLP-1 drugs. But there are hints.
Via
Investor's Business Daily
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
LLY stock struggles, falling 16.85% over the last month due to bearish technicals and political uncertainty. But with projected sales and earnings growth, could this be a buying opportunity?
Via
Benzinga
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
November 21, 2024
Shares of Lilly are cratering, but investors may be surprised to learn what's influencing the volatility.
Via
The Motley Fool
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
November 20, 2024
Eli Lilly and Verge Genomics advance ALS drug development with validated targets and a Phase 1B study, part of their $694 million collaboration since 2021.
Via
Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing.
Via
Benzinga
LLY Stock Rebounds Amid AI-Driven ALS Research Breakthroughs
November 20, 2024
Verge Genomics and Eli Lilly have made significant progress in their collaboration to develop ALS treatments, identifying two promising drug targets using AI technology.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.